How Robotics improve efficiency of Cell Therapy Manufacturing?

Does the term "needle to needle approach" mean anything to you? Are you interested in how other companies automate their biotech production? And would you like to know how the Chinese company Innovel is technically transferring this approach to its new IMMUNOBASE-System™ plant?

Get answers to these questions and more at our third episode of Stäubli Pharma Impulses on March 30, 2022, to which we cordially invite you.

Be excited as James Chen, Founder and Chief Engineer of Innovel Intelligent Technology (Suzhou), China, presents his customized full automation of cell production. Watch live as Chen and Rudolf M. Weiss, Global Head of Pharma Robotics, discuss the future of biotech manufacturing and its opportunities through automation.

Click here for registration.

We are looking forward to meeting you. 

Your Stäubli Robotics Team